Someone needs a heart transplant when their heart is too damaged or weak to keep them alive, and no other treatment can fix it. This is typically the result of end-stage heart failure, a point where the heart can no longer pump enough blood to meet the body’s basic needs. Nearly 4,000 people are on the U.S. heart transplant waiting list at any given time, each with a condition that has exhausted every other option.
End-Stage Heart Failure: The Core Reason
The vast majority of heart transplants happen because a person has reached the most advanced stage of heart failure. The American Heart Association classifies this as Stage D, defined as heart failure symptoms that disrupt daily life or repeatedly lead to hospitalization. At its worst, people experience symptoms even at rest, and any physical activity causes further discomfort.
Heart failure doesn’t mean the heart stops beating. It means the heart muscle has become too weak, too stiff, or too damaged to circulate blood effectively. Over time, fluid backs up into the lungs, the legs swell, and organs start to suffer from poor blood flow. When medications, lifestyle changes, and surgical procedures can no longer control these symptoms, transplant becomes the remaining path forward.
Conditions That Lead to Transplant
Several specific diseases can push the heart to the point of failure severe enough to warrant transplant.
Coronary Artery Disease
Blocked or narrowed arteries starve the heart muscle of oxygen. In many cases, stents or bypass surgery can restore blood flow. But when the damage is too widespread, when there aren’t enough healthy vessels left to operate on, or when the heart muscle itself has died and scarred over, those fixes stop working. Guidelines from the American Heart Association recommend that transplant evaluation begin once doctors confirm that bypass surgery isn’t feasible and the heart muscle is no longer viable enough to benefit from reopening the arteries.
Cardiomyopathy
This is a broad term for diseases of the heart muscle itself. In dilated cardiomyopathy, the heart chambers stretch and thin out, losing their ability to squeeze effectively. In hypertrophic cardiomyopathy, the walls thicken abnormally, making it harder for the heart to fill and empty. Restrictive cardiomyopathy stiffens the muscle so it can’t relax between beats. All three can progress to the point where the heart simply can’t do its job, regardless of medication.
Congenital Heart Defects
Some people are born with structural problems in the heart. Conditions like Ebstein’s anomaly, where a valve between heart chambers doesn’t form correctly, can be managed through childhood with surgeries and medication. But the heart often deteriorates over decades, and adults with congenital defects sometimes reach a point in their 30s, 40s, or later where transplant becomes the only viable option. Children with severe defects may need transplant much earlier.
Heart Valve Disease
Valves that leak or won’t open properly force the heart to work harder with every beat. Valve repair or replacement surgery usually solves this. But if the extra strain has already caused irreversible damage to the heart muscle, fixing the valve alone won’t be enough.
Dangerous Heart Rhythms
Life-threatening arrhythmias, where the heart beats chaotically or dangerously fast, can sometimes be controlled with implanted defibrillators or ablation procedures. When these fail and the arrhythmias keep recurring despite treatment, transplant may be the safest long-term solution.
How Doctors Decide You Need One
The decision isn’t made quickly. A transplant evaluation involves an extensive series of tests designed to measure exactly how poorly the heart is functioning and whether anything else can help. These typically include an echocardiogram (an ultrasound of the heart), an electrocardiogram to assess electrical activity, a stress test to see how the heart responds to exertion, and right heart catheterization, which measures pressures inside the heart chambers directly.
One of the most important tests is cardiopulmonary exercise testing, which measures how efficiently your body uses oxygen during physical activity. A very low score on this test is one of the strongest indicators that the heart is failing badly enough to justify transplant. Doctors also look at how often you’ve been hospitalized, whether you can perform basic daily activities, and how you’ve responded to every available medication and procedure.
The key principle is that transplant is a last resort. If there’s a less invasive option that might work, doctors will try it first. Bypass surgery, valve repair, medication adjustments, and implanted devices all get considered and often attempted before transplant enters the conversation.
Who Doesn’t Qualify
Not everyone with severe heart failure is eligible for a transplant. The surgery itself is grueling, and the lifelong medications required to prevent organ rejection take a toll on the body. Transplant centers evaluate whether a candidate is healthy enough in every other way to survive the process and benefit from a new heart.
Conditions that can disqualify someone include severe kidney or liver disease, active cancer or a cancer history within the past five years (other than skin cancer), serious blood vessel disease in the legs or brain, and diabetes that has already caused significant organ damage. Severe muscle wasting can also be disqualifying because recovery demands physical reserves.
The evaluation isn’t purely physical. Transplant teams assess whether a candidate has a strong support system of family or friends who can help during recovery, and whether the person demonstrates the commitment to follow a demanding post-transplant medication and monitoring schedule. These aren’t arbitrary hurdles. Donor hearts are scarce, and transplant centers need confidence that each organ goes to someone who can make the most of it.
Bridging the Gap With Mechanical Devices
Because donor hearts are in short supply, many patients approved for transplant receive a ventricular assist device, a mechanical pump surgically implanted in the chest. The device takes over much of the heart’s pumping work, keeping the patient alive and often improving their quality of life while they wait for a donor.
Some people live with these devices for months or even years. For patients who aren’t transplant candidates at all, the same device can serve as a permanent treatment. The technology has improved dramatically over the past two decades, and the devices have become smaller and more reliable, though they still require a power source connected through a cable that exits the skin.
What the Wait Looks Like
As of late 2025, roughly 3,929 people were on the U.S. heart transplant waiting list. Wait times vary widely depending on blood type, body size, how urgently the patient needs a heart, and geographic location. Patients listed as the highest urgency, often those in the hospital on mechanical support, tend to receive organs faster than those who are stable enough to wait at home.
During the wait, patients undergo regular check-ins to monitor their condition. If their health deteriorates, their priority status can be upgraded. If a new treatment improves their condition enough, they may be taken off the list entirely, which is actually a good outcome.
Life After Transplant
Survival rates after heart transplant are strong. About 92% of adult recipients survive the first year, and roughly 80% are alive five years later. Pediatric outcomes are similar, with about 84% survival at five years. These numbers have improved steadily over the decades as surgical techniques and anti-rejection medications have advanced.
The trade-off is a lifelong commitment to immunosuppressive drugs that prevent the body from attacking the new heart. These medications increase vulnerability to infections and certain cancers, and they require regular blood monitoring. Most recipients describe the adjustment as worthwhile. Many return to work, exercise, and daily activities that were impossible before the transplant.